Research Study Summary
Can you tell me about the study drug?
The Investigational drug being evaluated in the Harmony program is called albiglutide. This novel medication comes from a new class of drugs, which are similar to some types of currently approved diabetes drugs. However, albiglutide is designed to have a much longer-lasting effect.
Whereas some current diabetes medications must be administered multiple time a day by injection, researchers are expecting that one weekly injection albiglutide will prove to be effective in helping control type 2 diabetes.
All study participants receiving treatment with albiglutide will be given an injector pen. The study staff will instruct you on how to use this pen at home to administer your injections.
Why conduct medical research studies?
Medications must be carefully tested through medical research studies to demonstrate their safety and effectiveness before pharmaceutical companies are allowed to sell them to the public. Companies can tehn apply to regulatory agencies for approval to market these drugs to the public.
The researchers conducting this study are required to follow a detailed plan called a protocol, which explains all study procedures. This protocol is approved by an independent board and is designed to protect the safety of all study volunteers. Additionally, researchers must provide potentioal participants with complete answers to any questions they have about the study.
Medical research studies are necessary to test and, ultimately, develop new treatments for a wide variety of medical conditions. Your participation in the Harmony program may help researchers find a way to better control type 2 diabetes. However, your participation is completely voluntary, and you may leave the study at any time, for any reason.
To Learn more
CW ID: 156089
Date Last Changed:
July 24, 2013